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Summary. Background: Thrombophilia is a frequent medical
condition associated with symptomatic deep vein thrombosis
(DVT). Unlike other clinical risk factors associated with DVT,
suchas surgery, thrombophilia has not beendemonstrated tobe
associated with asymptomatic venous thrombotic events. Our
aim was to search for asymptomatic sequelae of DVT in a
protein C (PC)-deﬁcient family. Methods: We studied 228
individuals from a large kindred with PC deﬁciency and
performed a systematic ultrasound examination. Results:
Among the 203 patients without a known history of venous
thrombosis we found seven patients with abnormalities indic-
ative of prior asymptomatic thrombosis: six (7.4%) in the
PC-deﬁcient group (n ¼ 81) and only one (0.8%) in the non-
deﬁcient group (n ¼ 122). The relative risk for these sequelae
associated with PC deﬁciency was 9.0 (95% CI: 1.1–73.7).
Conclusions: These data suggest that chronic venous abnor-
malities are frequently present and that thrombotic events in
asymptomatic individuals with familial PC deﬁciency may be
underestimated.
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Introduction
Deep vein thrombosis (DVT) is a common disease among
patients who undergo surgery or who are hospitalized for an
acute medical problem [1]. Each year, about one in 1000 people
in industrialized countries develop deep venous thrombosis
(DVT) of the lower extremities [2,3]. Between 1% and 2% of
these patients will die from pulmonary embolism (PE), and as
many as 25% will suffer the chronic effects of the post-
thrombotic syndrome at 20 years after DVT [4]. Systematic
screening studies by bilateral ascending phlebography of
patients who had undergone orthopedic surgery or were
hospitalized for medical conditions have demonstrated that
asymptomatic DVT of the leg occurs at a rate of 40%–60% [5].
Furthermore, asymptomatic proximal DVT is found in
approximately 70% of patients who present clinical symptoms
of PE but no overt clinical symptom of DVT in the leg [6]. The
post-thrombotic syndrome is frequently observed in the general
population and has been widely assumed to be due to DVT
[7,8]. Post-thrombotic syndrome is caused by venous hyper-
tension, which most frequently occurs as a consequence of
either recanalization of a previousmajor vein thrombus that led
to valve destruction and reﬂux, or to persistent outﬂow
obstruction. Thrombophilia is a medical condition, which is
associated with an increased risk of symptomatic venous
thrombotic events [9,10]. We hypothesized that familial protein
C (PC) deﬁciency, a well-recognized cause of thombophilia,
might also be associatedwith an increased risk of asymptomatic
venous thrombotic events. Review of the literature reveals that
this has not been systematically assessed to date. We thus
systematically assessed by ultrasound (US) a large kindred with
PC deﬁciency to look for venous reﬂux and/or obstruction.
Methods
Population
We evaluated a large PC-deﬁcient kindred of French Canadian
origin [11–13]. The study included 228 individuals from
northeastern USA and Que´bec, Canada, with or without a
history of symptomatic DVT or PE, and with or without PC
deﬁciency. All individuals belonging to a single large extended
family with a high rate of venous thrombosis partially
attributable to type I PC deﬁciency because of a 3363 InsC
mutation in the PC gene. The pedigree spans six generations,
and individuals aged 18 and older from the most recent four
generations were all consecutively studied between July 2002
and March 2003. The University of Vermont, Burlington,
Vermont, USA and Laval University Quebec City, Quebec,
Canada Committees on Human Research approved the
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experimental protocol and all subjects provided informed
consent. Symptomatic subjects included family members who
had a history of venous thrombosis, conﬁrmed through
objective tests: phlebography or echography for DVT and
pulmonary angiography, helical computed tomography (CT)
scan or ventilation/perfusion scintigraphy for PE. Patients were
deﬁned as asymptomatic, according to the absence of a
personal clinical history of venous thrombosis and the absence
of objective anomaly in the lower limb according to the
validated CEAP venous scoring system [14,15].
Ultrasound examination
Patients were assessed clinically using the CEAP scoring system
[14] and then an echo-Duplex US examination was systemat-
ically performed, as recently described [13]. Brieﬂy, a venous
US was performed on each patient with the SonoSiteTM
180PLUS (SonoSite, Inc., Bothell, WA, USA) a lightweight,
portable system. Transverse compressions were performed
from the common femoral vein just below the inguinal
ligament down to the popliteal and sural veins, including the
superﬁcial veins. The US criteria for identiﬁcation of venous
sequelae of the lower limbs were deﬁned before patient
enrollment. Reﬂux was deﬁned as abnormal valve closure
times that produced reversal of venous ﬂow of >0.5 s [7,13].
One individual (J.E.) performed all clinical examinations and
venous US examinations and was blinded with respect to the
subjects medical histories of venous thrombosis and their PC
deﬁciency status.
Protein C genotype
Patients from Quebec were genotyped at the University of
Laval, Quebec City, Quebec, Canada and patients from the
USA were genotyped at the University of Vermont College of
Medicine, Burlington, VT [16,17].
Statistical analysis
Relative risks were calculated by taking the ratio of the
proportions of venous sequelae among individuals with or
without PC deﬁciency. We used stratiﬁcation to adjust for age
and sex by computing adjustedMantel–Haenszel relative risks.
Results
The characteristics of the 228 patients studied are depicted in
Table 1. The 3363 insertionmutation in the PC gene was found
in 102 subjects (45%). A history of DVT or PE was reported
by, respectively, 21% and 3% of the PC-deﬁcient and normal
subjects. Considering the entire group (with or without a
history of venous thrombosis), 23 venous abnormalities (10%)
were found by US examination (obstruction or reﬂux); 19 in
the 102 subjects (19%) who carried the PC mutation, and four
in the 126 (3%) who did not (adjusted relative risk: 3.8; 95%
CI: 1.6–9.3). Among the 25 patients with a known history of
venous thrombosis, one had experienced an isolated PE and
one had a history of DVT of the arm. In the 23 remaining
patients with a history of DVT in the lower limb, 16 had DVT
sequelae on US examination (eight partial obstruction associ-
ated with reﬂux and eight reﬂux without obstruction). Among
these 16 patients (Table 2), no difference was observed in the
incidence of venous abnormalities between patients with or
without PC deﬁciency (adjusted relative risk: 1.2; 95%CI: 0.7–
1.9). Among the 203 patients with no known history of venous
thrombosis we found seven patients with signiﬁcant abnormal
popliteal valve closure times: six (7.4%) in the PC-deﬁcient
group and only one (0.8%) in the non-deﬁcient group. Three of
these seven patients had also partial obstruction of the vein.
The relative risk for the ﬁnding of deep vein reﬂux associated
with PC deﬁciency was 9.0 (95%CI: 1.1–73.7). Adjustment for
age and sex did not change the relative risk (8.3; 95% CI: 1.0–
70.6). Clinical ﬁnding among these patients with venous
abnormalities and no history of VTE were analyzed according
to the CEAP classiﬁcation. Five patients were asymptomatic
Table 1 Characteristics of the population
Total PC-deﬁcient Non-PC-deﬁcient
Number 228 102 126
Mean age (range) 43 (15–80) 46 (18–80) 41 (15–78)
Men, n (%) 102 (45) 39 (38) 63 (50)
History of DVT
or PE, n (%)
25 (11) 21 (21) 4 (3)
History of DVT,
n (%)
23 (10) 19 (19) 4 (3)
PC, protein C; DVT, deep vein thrombosis; PE, pulmonary embolism.
Table 2 Frequency of DVT sequelae assessed by functional ultrasound and relative risk according to PC status
PC-deﬁcient (N ¼ 102) Non-PC-deﬁcient (N ¼ 126) RR (95% CI)
Number of subjects with a history of DVT/PE 21 4
Number of DVT sequelae 13 (62%) 3 (75%) 0.8 (0.4–1.6)
1.2 (0.7–1.9)*
Number of subjects with no history of DVT/PE 81 122
Number of DVT sequelae 6 (7.4%) 1 (0.8%) 9.0 (1.1–73.7)
8.3 (1.0–70.6)*
PC, protein C; DVT, deep vein thrombosis; PE, pulmonary embolism; RR, relative risk; CI, conﬁdence interval.
*Relative risk adjusted for age and sex via stratiﬁcation.
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and two report intermittent pain in their leg. Varicose veins
were found in two patients (CEAP 2S and 2A, respectively) and
telangiectases in one other patient (CEAP 1A). Two patients
without aching hadmild edema on clinical examination (CEAP
3A) and another one had skin pigmentation attributed to
venous disease (CEAP 4A). Interestingly, the only patient with
venous abnormalities and no PC deﬁciency had a history of
severe traumatic injury with a tibial fracture of the affected leg
and a 2-week stay in the intensive care unit. Superﬁcial venous
thrombosis sequelae were found in three and ﬁve of the
PC-deﬁcient and non-deﬁcient subjects respectively.
Among individuals without a history of venous thrombosis,
individuals with sequelae (n ¼ 7) compared to those without
sequelae (n ¼ 196) showed a higher body mass index (mean
BMI 30.9 vs. 28.0 kg m)2 respectively) and a higher number of
major surgeries in the past (e.g. hernia operations, hysterec-
tomies; 71% vs. 51% respectively). Among individuals with a
history of venous thrombosis, BMI was slightly higher in
individuals with sequelae (n ¼ 16) compared to those without
sequelae (n ¼ 9; mean BMI 28.4 and 26.8 kg m)2 respectively)
as well as the number of major surgeries (69% vs. 56%
respectively).
Discussion
In this large kindred of genotyped thrombophilic subjects, we
found a 7.4% incidence of deep venous valvular incompetence
among those with PC deﬁciency and no history of venous
thrombosis, using an objective US examination study per-
formed blinded with respect to the personal medical history
and the PC status. In a large epidemiologic study, including
2211men and women in SanDiego, Criqui et al. demonstrated
a strong association of deep thrombotic events with deep
valvular insufﬁciency, evaluated by reﬂux duration or Valsalva
reﬂux of more than 0.5 s [18]. The present study is the ﬁrst to
demonstrate that deep venous valvular incompetence,
which mainly reﬂects DVT sequelae, is a frequent event in
PC-deﬁcient patients with no history of DVT. This observation
thus demonstrates a higher incidence of DVT in PC-deﬁcient
patients than the incidence depicted by clinical history alone. It
is possible that the frequency of 7.4% is also an underestimate,
as the sensitivity of US to detect sequelae in our population
with a known history of lower limb DVT was only 70% in our
study. Nevertheless, the results of a systemic review of US in
the diagnosis of DVT in asymptomatic patients demonstrate
that it is an accurate means to detect proximal DVT, with a
mean sensitivity estimated to be 80% [19]. There is no gold
standard test for the diagnosis of post-thrombotic syndrome or
DVT sequelae. The detection of venous valvular incompetence
by Doppler US, as performed in our protocol, is a validated
method to objectively diagnose venous reﬂux and obstruction
[4,13].
The clinical signiﬁcance of asymptomatic DVT is debated
in both thrombophilic and postsurgical patients [20]. After
surgery, systematic screening for DVT revealed that around
half of asymptomatic DVT resolve spontaneously and only
one-sixth extend to the proximal vein with a risk of PE [21].
Furthermore, whether asymptomatic DVT, detected by
routine screening, leads to post-thrombotic syndrome remains
controversial [4]. For these reasons, although we demonstra-
ted a ninefold increased risk of asymptomatic DVT among
PC-deﬁcient individuals, these ﬁndings do not allow us to
draw clinical conclusions about thromboprophylaxis or
treatment of patients with PC deﬁciency or other forms of
thrombophilia. Furthermore, as discussed above, we cannot
exclude that some instances of deep valvular reﬂux are not
related to previous DVT. Nevertheless, our study clearly
demonstrates that asymptomatic events, detected by a
functional US examination, are frequent in patients with
PC deﬁciency. The clinical signiﬁcance of this ﬁnding remains
to be demonstrated in future studies of thrombophilic
populations. The risk of recurrent thrombosis is increased
in patients with residual venous thrombosis after a sympto-
matic proximal DVT compared to patients with complete
recanalization [22]. In the study by Prandoni et al., this
observation applied to patients with idiopathic DVT, with
thrombosis secondary to transient risk factors, as well as
patients with thrombophilic abnormalities. Thus, despite the
fact that our study was not designed to demonstrate an
increased risk of DVT in the subgroup of patients with DVT
sequelae, it seems likely that these individuals would be at
increased risk for DVT.
Finally, our study opens a new ﬁeld in the evaluation of
thrombophilia. To date only two phenotypes have been
described in clinical studies related to DVT and thrombo-
philia: symptomatic and asymptomatic patients. Our ﬁndings
demonstrate the misclassiﬁcation of a substantial number of
asymptomatic patients who should be reclassiﬁed as asymp-
tomatic with sequelae of DVT. Although the clinical utility
of this reclassiﬁcation remains to be determined, the
increased reﬁnement of phenotype deﬁnition should be useful
in the search for gene–gene interaction in this polygenic
disease [12].
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